Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital
NCT ID: NCT04736680
Last Updated: 2021-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3339 participants
OBSERVATIONAL
2021-03-01
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-attendance Prediction Models to Pediatric Outpatient Appointments
NCT06077630
Virtually-integrated Co-management Between Complex Care and Community-based Primary Care Providers
NCT03530709
Evaluation of Knowledge About Fever After Consultation in the Pediatric Emergency Department
NCT04925401
Feasibility and Quality of TeleConsultation in Pediatric Anesthesia
NCT04583865
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
NCT04867395
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to overcome this barrier in access to care, we decided to implement a Telehealth Program that uses virtual visits as a tool for access to care. Little is known about the effects that these programs can have on patients with exclusive public health coverage. Although virtual visits could be a solution for access to care in an oversaturated system, there is the possibility that virtual visits could not be carried out and that a significant proportion will be lost, increasing inequity and difficulties in access to health.
Due to the relevance of the topic and the little information available, we propose in this study to estimate the proportion of virtual visits appointments lost. On the other hand, considering the possibility of avoiding the loss of virtual visits appointments, we propose to describe the factors associated with missed appointments and develop a predictive model that serves as the basis for improving the Telehealth Program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lost Virtual Visit
Pediatric patients who had scheduled an appointment for a virtual visit and missed.
No interventions assigned to this group
Attended Virtual Visit
Pediatric patients who had scheduled an appointment for a virtual visit and attended.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Month
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital General de Niños Pedro de Elizalde
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariano E Ibarra, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital General de Niños Pedro de Elizalde
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital General de Niños Pedro de Elizalde
Buenos Aires, , Argentina
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2392
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.